BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• BioCapital

  Immunocore presents new KIMMTRAK data confirming association between early ctDNA reduction and longer overall survival

  Immunocore Holdings plc has presented four posters with KIMMTRAK data in HLA-A*02:01 patients with metastatic uveal melanoma, at the 2023 American Association for Cancer Research Annual Meeting 2023.

  April 18, 2023

   · 

  12 min read
• Medicenna to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference

  Medicenna Therapeutics Corp. today announced that Dr. Fahar Merchant, President and CEO of Medicenna, will participate in a fireside chat and management will participate in one-on-one meetings at the 2023 Bloom Burton & Co. Healthcare Investor Conference.

  April 18, 2023

   · 

  1 min read
• Drug Development

  Surface Oncology Presents New Preclinical Data on SRF114, a fully human anti-CCR8 antibody, at the AACR Annual Meeting 2023

  Surface Oncology today announced the presentation of new preclinical data for SRF114, a fully human anti-CCR8 antibody, at the American Association for Cancer Research (AACR) Annual Meeting 2023 in Orlando, Florida.

  April 18, 2023

   · 

  3 min read
• Genetown

  Sigilon Therapeutics to Present at the Needham Virtual Healthcare Conference

  Sigilon Therapeutics, Inc. today announced that its President and Chief Executive Officer, Rogerio Vivaldi, M.D., will present a corporate overview during the Needham Virtual Healthcare Conference.

  April 18, 2023

   · 

  1 min read
• Bio NC

  BioCryst Refinances Existing Debt with $450 Million Financing Commitment from Pharmakon

  BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company has secured $450 million in committed financing from funds managed by Pharmakon Advisors, LP. BioCryst has elected to draw $300 million of the $450 million available to the company on the closing date.

  April 18, 2023

   · 

  4 min read
• Identifai-Genetics Closes a Post-Seed Fundraising Round of USD 3.3M; Dr. Susan Gross, former CMO at Natera, named as Chief Strategic Advisor

  Identifai-Genetics announced today that it has completed a post-seed fundraising round of USD 3.3M.

  April 18, 2023

   · 

  3 min read